Market Tracker

09/30 1:53pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.25
Real-Time Quote
 -0.20 / -2.12%
Today’s Change
6.88
Today|||52-Week Range
18.18
-38.29%
Year-to-Date

Today’s Trading

Previous close9.45
Today’s open9.43
Day’s range9.10 - 9.44
Volume580,526
Average volume (3 months)1,298,473
Market cap$1.2B
Dividend yield--
Data as of 1:35pm ET, 09/30/2014

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+13.68%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc-0.73-2.53%
OPHTOphthotech Corp-0.18-0.46%
BLUEbluebird bio Inc-1.01-2.74%
NVAXNovavax Inc-0.09-2.08%
Data as of 1:52pm ET, 09/30/2014

Financials

Next reporting dateNovember 7, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts